Adragos Pharma will be part of the NLSDAYS 2026 event in the Nordic life sciences ecosystem.

Adragos Pharma is an internationally operating contract development and manufacturing organization headquartered in Germany. As a reliable partner, the company offers comprehensive services for drug products across small and large molecules, including end-to-end production of small molecule finished dosage forms - sterile and non-sterile liquids, solids, and semi solids - as well as fill and finish of biologics in glass vials and pre-filled syringes. Adragos currently operates six production sites in France, Germany, Norway, Switzerland, and Japan, and a development site in Greece.